Unlock instant, AI-driven research and patent intelligence for your innovation.

Sustained-release pasireotide microsphere and preparation method thereof

A pasireotide and microsphere technology, applied in cyclic peptide components, pharmaceutical formulations, microcapsules, etc., can solve the problems of slow release, long action and short action time of microspheres, and achieve uniform particle size and high encapsulation efficiency. , the effect of simple preparation process

Active Publication Date: 2020-03-10
HYBIO PHARMA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] In the prior art, the drug is prepared as an injection, which has a shorter action time in the body; while the microspheres are relatively slow in release and have a longer action time in the body.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sustained-release pasireotide microsphere and preparation method thereof
  • Sustained-release pasireotide microsphere and preparation method thereof
  • Sustained-release pasireotide microsphere and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] Preparation of the internal water phase: weigh 100 mg of pasireotide and water, vortex and shake to dissolve, weigh the prescription amount of mannitol 100 mg, add to the pasireotide aqueous solution for dispersion, and dissolve in a water bath to obtain the internal water phase;

[0057] Preparation of the outer water phase: Measure an appropriate amount of purified water, add 50mg of polyvinyl alcohol, heat and stir to dissolve, and get the outer water phase solution after passing through the gauze;

[0058] Preparation of oil phase: Weigh 0.8g PLGA dissolved in 30g methylene chloride as the oil phase;

[0059] Preparation of colostrum: transfer the dissolved oil phase to the internal water phase and stir at high speed (2000rpm) for 20 seconds to obtain colostrum;

[0060] Preparation of double emulsion: add the colostrum to the polyvinyl alcohol solution under stirring to obtain the double emulsion, continue to stir the double emulsion to evaporate the organic solvent, centri...

Embodiment 2

[0062] Preparation of the internal water phase: Weigh 120mg of pasireotide and water, vortex and shake to dissolve, weigh the prescription amount of hypromellose 180mg, add to the pasireotide aqueous solution to disperse, water bath to dissolve to obtain the internal water phase ;

[0063] Preparation of the outer water phase: Measure an appropriate amount of purified water, add 200 mg of Tween, heat and stir to dissolve, and obtain the outer water phase solution after passing through the gauze;

[0064] Preparation of the oil phase: Weigh 1.0g PLGA dissolved in 30g ethyl acetate as the oil phase;

[0065] Preparation of colostrum: transfer the dissolved oil phase to the internal water phase and use high-speed stirring (16000rpm) for 30 seconds to obtain colostrum;

[0066] Preparation of double emulsion: add colostrum to 200 mg Tween solution under stirring to obtain double emulsion, continue stirring the double emulsion to evaporate the organic solvent, centrifuge, wash and collect ...

Embodiment 3

[0068] Preparation of internal water phase: Weigh 120mg of pasireotide and water, vortex and shake to dissolve, weigh the prescription amount of mannitol 180mg, add to the pasireotide aqueous solution for dispersion, water bath to dissolve, then add 100mg of human serum white Protein, 100mg gum arabic suspending agent was added at the same time to obtain the internal water phase;

[0069] Preparation of the outer water phase: Measure an appropriate amount of purified water, add 120mg of polyvinyl alcohol with the prescription amount, heat and stir to dissolve, and obtain the outer water phase solution after passing through the gauze;

[0070] Preparation of the oil phase: Weigh 1.1 g of PLGA dissolved in 30 g of dichloromethane as the oil phase;

[0071] Preparation of colostrum: transfer the dissolved oil phase to the internal water phase and use high-speed stirring (16000rpm) for 30 seconds to obtain colostrum;

[0072] Preparation of double emulsion: add the colostrum to the polyvi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a sustained-release pasireotide microsphere and a preparation method thereof, and in particular to a sustained-release pareotide microsphere. The microsphere consists of pasireotide serving as an active ingredient, a microsphere carrier polymer, a protective agent, a surfactant and a suspending aid, wherein the microsphere carrier polymer is selected from poly(lactide-co-glycolide), and the suspending aid is one or a combination of more selected from a group consisting of tragacanth gum, Arabic gum, carbomer and sodium alginate. The pareotide microsphere prepared by amultiple emulsion method has a simple preparation process, and microspheres with uniform particle size, high encapsulation rate and stable quality can be prepared. Through addition of the suspending aid, release of the pareotide microspheres is increased from 95% in 14 days to 95% in 28 days.

Description

Technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a slow-release pasireotide microsphere and a preparation method thereof. Background technique [0002] Pasireotide injection is a somatostatin analog, mainly used to treat patients with Cushing's disease that cannot be treated by surgery. Cushing’s disease is the proliferation of ACTH adenomas or ACTH cells of the pituitary, which secretes too much ACTH and causes adrenal cortex hyperplasia, resulting in hypercortisolism, leading to a series of material metabolism disorders and pathological changes. Pasireotide inhibits ACTH secretion, thereby reducing the secretion of cortisol. [0003] Pasireotide injection has been approved by the US FDA, but due to its short half-life, it needs to be injected subcutaneously twice a day. The compliance is very poor, so the development of a sustained-release microsphere formulation that can be administered once a month can improve patient ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/52A61K38/12A61K47/34A61P5/02
CPCA61K9/0019A61K9/5031A61K38/12A61P5/02A61K9/16A61K47/34A61P5/38
Inventor 张伟明辛永涛陶安进袁建成
Owner HYBIO PHARMA